Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer’s Association International Conference
July 28, 2025
Health
-
-
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD
July 17, 2025
-
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
July 17, 2025
-
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
July 14, 2025
-
NEXGEL and STADA AG Announce Expansion of Partnership for North America
July 14, 2025
-
Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100
July 10, 2025
-
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant(TM) Medical Holdings, Inc.
July 8, 2025
-
Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework
July 7, 2025
-
Safety Shot Completes Acquisition of Yerbae Brands Corp.
June 27, 2025
-
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
June 27, 2025
-
Ontrak Health Announces Pricing of $4 Million Public Offering
June 27, 2025
-
MEME Coins Inc. Closes Acquisition of 1 Billion Dogecoin Cash (DOG) Tokens from Tipestry Inc.
June 5, 2025
-
Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
May 27, 2025
-
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
May 22, 2025
-
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
May 22, 2025
-
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
May 21, 2025